![]() | A major contributor to this article appears to have a
close connection with its subject. (February 2019) |
![]() | |
Company type | Private |
---|---|
Industry | Biotechnology |
Founded | 2003 |
Founders | Sridhar Govindarajan, Claes Gustafsson, Jeremy Minshull, Jon Ness |
Headquarters | , |
Products | Artificial gene synthesis, protein engineering, protein production, bioinformatics, cell line development, transposases |
ATUM is an American biotechnology company. ATUM provides tools for the design and synthesis of optimized DNA, as well as protein production and GMP cell line development.
ATUM (formerly DNA2.0) was founded in 2003, in Menlo Park, California. The company is privately held [1] and continues to have all research, development and production in California, currently in their 50,000 sq ft Newark facility. [2] It began and continues as a gene synthesis and protein engineering provider to academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. Gene synthesis rapidly replaced molecular cloning for many academic and corporate labs, as "foundries for the biotechnology age" allowing made-to-order genes for biological research. [3]
DNA2.0 was featured on the PBS show Nova ScienceNow [4] to show how genes are created synthetically in a lab. In 2008, the company supplied some of the DNA stretches used to create a synthetic bacterial genome. [5]
Dan Rather Reports included DNA2.0 in their episode on synthetic biology [6] and how the field is solving "some of the most important problems facing the world." [6]
In 2009, The Scientist named the codon design algorithms [7] (now trademarked as GeneGPS) developed by DNA2.0 as one of the "Top 10 Innovations" of the year for life sciences. [8] ATUM developed the Electra Vector System, a universal cloning system that utilizes the type IIS restriction enzyme SapI and T4 DNA ligase in a single-tube reaction. [9] ATUM has made some molecular components, such as synthetic fluorescent proteins, available in open-access collections of DNA parts ( BioBricks Foundation). [10] Atum is a founding member of the International Gene Synthesis Consortium (IGSC) to promote biosecurity in the gene-synthesis industry. [11] [12] There are over 1,200 [13] published scientific articles using DNA2.0 products and/or services, of which 44 [14] include company employees as authors.
![]() | A major contributor to this article appears to have a
close connection with its subject. (February 2019) |
![]() | |
Company type | Private |
---|---|
Industry | Biotechnology |
Founded | 2003 |
Founders | Sridhar Govindarajan, Claes Gustafsson, Jeremy Minshull, Jon Ness |
Headquarters | , |
Products | Artificial gene synthesis, protein engineering, protein production, bioinformatics, cell line development, transposases |
ATUM is an American biotechnology company. ATUM provides tools for the design and synthesis of optimized DNA, as well as protein production and GMP cell line development.
ATUM (formerly DNA2.0) was founded in 2003, in Menlo Park, California. The company is privately held [1] and continues to have all research, development and production in California, currently in their 50,000 sq ft Newark facility. [2] It began and continues as a gene synthesis and protein engineering provider to academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. Gene synthesis rapidly replaced molecular cloning for many academic and corporate labs, as "foundries for the biotechnology age" allowing made-to-order genes for biological research. [3]
DNA2.0 was featured on the PBS show Nova ScienceNow [4] to show how genes are created synthetically in a lab. In 2008, the company supplied some of the DNA stretches used to create a synthetic bacterial genome. [5]
Dan Rather Reports included DNA2.0 in their episode on synthetic biology [6] and how the field is solving "some of the most important problems facing the world." [6]
In 2009, The Scientist named the codon design algorithms [7] (now trademarked as GeneGPS) developed by DNA2.0 as one of the "Top 10 Innovations" of the year for life sciences. [8] ATUM developed the Electra Vector System, a universal cloning system that utilizes the type IIS restriction enzyme SapI and T4 DNA ligase in a single-tube reaction. [9] ATUM has made some molecular components, such as synthetic fluorescent proteins, available in open-access collections of DNA parts ( BioBricks Foundation). [10] Atum is a founding member of the International Gene Synthesis Consortium (IGSC) to promote biosecurity in the gene-synthesis industry. [11] [12] There are over 1,200 [13] published scientific articles using DNA2.0 products and/or services, of which 44 [14] include company employees as authors.